Initial comparison of descriptive statistics for all clinical variables was performed using either analysis of variance or chi-squared tests, depending on whether the variables were quantitative or categorical. To allow comparison among studies, the ARCS scores were then standardized (to Z scores) using the mean and SD of the normal population reported by Schofield et al. 21 Bivariate linear correlation analysis of standardized ARCS scores was performed using Pearson’s (r) coefficient tests. Because moderate outliers were observed for some of the cognitive variables, we performed a secondary check of the Pearson’s correlation analyses by using Spearman’s (rho) tests, which are robust to outlier effects. These tests yielded results showing consistent strength and significance for all bivariate tests, thus adding confidence that the Pearson’s (r) results were not affected by outliers. For each regression model, we entered each of the mental health measures as the main effect factors so as to approximate the relative contribution of each mental health factor on cognitive function while accounting for the others. Tests for normality of outcome variables were performed using Q-Q plots and Kolmogorov-Smirnov goodness-of-fit tests. These tests showed some modest deviations from normality for language and visual domains, but these were not deemed substantial enough to warrant transformation. e., sex, age at initial assessment, age at diagnosis, disease duration, EDSS, treatment type, MS subtype, annual relapse rate, other mental health medications, and education level. To account for multicolinearity, and so as not to overburden each regression model with too many uninformative parameters, we chose to include all main effect factors and covariates in a step-wise fashion using an algorithm that only retained covariates if they contributed to the overall regression model (p<0.05). In an effort to discern the relative association of the three mood indices from each other, and in relation to the other clinical covariates, we partitioned our regression models to include forced entry of each mood index separately, with all other clinical covariates entered in a step-wise fashion, and forced entry of all three mood indices combined, with all other clinical covariates entered in a step-wise fashion. Because we tested six different hypotheses (i.e., six cognitive function outcomes), we used the Bonferroni correction method to adjust the significance level to 0.008 (i.e., 0.05/6). In addition, we retained results at the “suggestive” level of 0.05 to provide an indication of association trends.
Show
The latest descriptive attributes with the MS subtypes are offered inside the Table step one. Seventy-9 % of our own cohort had been classified once the relapsing remitting (RRMS), 14% had been secondary modern (SPMS), and you may 7% priS) MS. Customers acquiring MS-certain immunomodulatory service have been mostly RRMS patients and had been searching interferon beta (N=89), glatiramer acetate (N=42), natalizumab (N=25), fingolimod (N=9), dimethyl fumarate (N=4), or no MS immunomodulatory medication (N=153) during the time of creating the analysis examination. SPMS customers were older, got a lengthier duration of condition https://datingranking.net/sober-dating/, along with increased EDSS peak than simply their RRMS counterparts on the time of assessments. Utilizing the severity grading standards each mood directory with the DASS, twenty four the seriousness of psychological episodes are evaluated. Within our MS cohort, 12% regarding people said big otherwise very major anxiety, which have 14% scoring moderate levels of stress (Contour step 1). Thirty-one percent had been receiving treatment having a beneficial serotonin reuptake inhibitor on the full time out of performing cognitive assessment. Centered on the concept of cognitive impairment (come across above), 34% of one’s MS cohort was basically cognitively dysfunctional.
I as well as integrated a good amount of probably important covariates for the for every single of your own regression activities, we
Figure 1. Delivery from Mood Indices regarding the Multiple Sclerosis (MS) Cohort Appearing Proportions of People at each Level of Severity a beneficial